Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06275555
NA
Use of Bivalirudin for Anticoagulation in Patients With Extracorporeal Membrane Oxygenation
Sponsor: Xiaotong Hou
View on ClinicalTrials.gov
Summary
The purpose of this study was to evaluate the efficacy and safety of bivalirudin in anticoagulation therapy in patients with extracorporeal membrane oxygenation (ECMO) compared with unfractionated heparin.
Official title: Efficacy and Safety of Bivalirudin Versus Heparin in Anticoagulant Therapy of ECMO: a Randomized Controlled Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
154
Start Date
2024-06-03
Completion Date
2027-03-01
Last Updated
2026-04-06
Healthy Volunteers
No
Interventions
DRUG
bivalirudin
bivalirudin as an anticoagulant
DRUG
unfractionated heparin
unfractionated heparin as an anticoagulant
Locations (1)
Beijing Anzhen Hospital
Beijing, Beijing Municipality, China